Christoph Schwärzler

Author

Novartis (Austria)

Also Known As

C SCHWARZLER, C Schwarzler, C Schwärzler, C. Schwärzler, Christoph Schwärzler, Christoph Schwärzler, Kirsten Tangemann

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Novartis (Austria)German Cancer Research Center Heidelberg University Institute of Molecular and Clinical Ophthalmology Basel University of Tübingen

About

Christoph Schwärzler is an author at Novartis (Austria) specializing in immunology, medicine, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1K
2	Allergy	5	5	295
3	Cell Biology	5	5	666
4	Gastroenterology	2	2	121
5	Clinical Immunology	1	1	66

Christoph Schwärzler

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity Tina Rubic, Günther Lametschwandtner, Sandra Jost, Nature Immunology InflammationInnate Immune SystemImmunologyAutoimmunityT Cell Immunity	2008	495
Analysis of Cd44-Containing Lipid Rafts Snezhana Oliferenko, Karin Paiha, Thomas Harder, The Journal of Cell Biology	1999	402
CCL18 Is Expressed in Atopic Dermatitis and Mediates Skin Homing of Human Memory T Cells Claudia Günther, C Bello-Fernández, Tamara Kopp, The Journal of Immunology Immune RegulationImmunologyImmunologic MechanismDermatologyT Cells	2005	152
Abrogation of Experimental Colitis Correlates with Increased Apoptosis in Mice Deficient for Cd44 Variant Exon 7 (Cd44v7) Bianca M. Wittig, Britt Johansson, Margot Zöller, The Journal of Experimental Medicine	2000	125
Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo Tilo Biedermann, Christoph Schwärzler, Günther Lametschwandtner, European Journal of Immunology Immune RegulationImmunologySkin AllergyImmunologic MechanismDermatology	2002	105
Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities Günther Lametschwandtner, Tilo Biedermann, Christoph Schwärzler, Journal of Allergy and Clinical Immunology	2004	68
Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody. Bianca M. Wittig, Christoph Schwärzler, Nicole Föhr, PubMed Clinical ImmunologyImmunologyGastroenterologyImmune RegulationPathology	1998	66
Cutting Edge: Curative Treatment of an Experimentally Induced Colitis by a CD44 Variant V7-Specific Antibody Bianca M. Wittig, Christoph Schwärzler, Nicole Föhr, The Journal of Immunology Chronic Inflammatory DiseasesImmunologyGastroenterologyPathologyImmune Regulation	1998	55
Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide Jon D. Laman, C.B.M. Maassen, Marc M. Schellekens, Multiple Sclerosis Journal	1998	54
Different CD44 splicing patterns define prognostic subgroups in multiple myeloma Reinhard Stauder, Marjolein van Driel, Christoph Schwärzler, Blood	1996	52

Page 1